Cargando…
Effectiveness of inactivated and Ad5-nCoV COVID-19 vaccines against SARS-CoV-2 Omicron BA. 2 variant infection, severe illness, and death
BACKGROUND: Limited data are available on the effectiveness of inactivated and Ad5-nCoV COVID-19 vaccines in real-world use—especially against Omicron variants in SARS-CoV-2 infection-naïve population. METHODS: A matched case-control study was conducted among people aged ≥ 3 years between 2 December...
Autores principales: | Huang, Zhuoying, Xu, Shuangfei, Liu, Jiechen, Wu, Linlin, Qiu, Jing, Wang, Nan, Ren, Jia, Li, Zhi, Guo, Xiang, Tao, Fangfang, Chen, Jian, Lu, Donglei, Sun, Xiaodong, Wang, Weibing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583051/ https://www.ncbi.nlm.nih.gov/pubmed/36266697 http://dx.doi.org/10.1186/s12916-022-02606-8 |
Ejemplares similares
-
Effectiveness of inactivated COVID-19 vaccines among older adults in Shanghai: retrospective cohort study
por: Huang, Zhuoying, et al.
Publicado: (2023) -
Neutralizing antibody levels associated with injectable and aerosolized Ad5-nCoV boosters and BA.2 infection
por: Wang, Fuzhen, et al.
Publicado: (2023) -
Neutralization of SARS-CoV-2 Omicron BA.1, BA.4, and BA.5 by primary ChAdOx1 nCoV-19, mRNA-1273, MVC-COV1901 and booster mRNA-1273 vaccination
por: Liu, Yuag-Meng, et al.
Publicado: (2022) -
Monovalent vaccination with inactivated SARS-CoV-2 BA.5 protects hamsters against Omicron but not non-Omicron variants
por: Ong, Chon Phin, et al.
Publicado: (2023) -
Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants
por: Yu, Jingyou, et al.
Publicado: (2022)